James R Neal's Net Worth

$6.64 Million

Estimate Recalculated Sep 18, 2025 08:28PM EST

Who is James R Neal

James R Neal has an estimated net worth of $6.64 Million. This is based on reported shares across multiple companies, which include XOMA Corp, Monterey Bio Acquisition Corp, PALISADE BIO, INC., Processa Pharmaceuticals, Inc., and Peak Bio, Inc..

SEC CIK

James R Neal's CIK is 0001600865

Past Insider Trading and Trends

2021 was James R Neal's most active year for acquiring shares with 9 total transactions. James R Neal's most active month to acquire stocks was the month of January. 2017 was James R Neal's most active year for disposing of shares, totalling 15 transactions. James R Neal's most active month to dispose stocks was the month of October. 2015 saw James R Neal paying a total of $277,675.00 for 125,000 shares, this is the most they've acquired in one year. In 2022 James R Neal cashed out on 156,900 shares for a total of $2,299,910.64, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

XOMA Corp

CEO
Updated Jul 18, 2022
Form 4
-9.81%
-25.00K
$16.93
-$645.35K
Jul 18, 2022
251.44K
Sale
Scheduled
Jul 15
Form 4
-31.80%
-53.45K
$16.55
-$1.34M
Mar 23, 2022
136.18K
Sale
Mar 21 - Mar 23
Form 4
60.00K
Dec 23, 2021
60.00K
Grant
Dec 21
Form 4
-43.30%
-9.03K
$33.62
-$303.47K
Jun 29, 2021
32.79K
Sale
Jun 25
Form 4
8.00K
$25.00
$200.00K
Apr 13, 2021
41.82K
Grant
Apr 09
Form 4
60.27K
Feb 19, 2021
60.27K
Grant
Feb 17
Form 4
-38.42%
-18.00K
$28.30
-$732.00K
Dec 17, 2020
33.52K
Sale
Scheduled
Dec 15
Form 4
-29.92%
-20.00K
$19.16
-$546.18K
Nov 24, 2020
51.52K
Sale
Scheduled
Nov 20 - Nov 23
Form 4
-13.01%
-10.00K
$15.76
-$205.20K
Nov 06, 2020
71.52K
Sale
Scheduled
Nov 05
Form 4
5.04%
1.00K
$14.50
$14.50K
Mar 24, 2020
25.52K
Purchase
Mar 23
Form 4
5.31%
1.00K
$16.41
$16.41K
Mar 23, 2020
24.52K
Purchase
Mar 20
Form 4
66.20K
Mar 16, 2020
66.20K
Grant
Mar 13
Form 4
$22.00
$25.96K
Jan 16, 2020
23.52K
Options
Dec 23
Form 4
-5.57%
-4.35K
$13.75
-$71.74K
Nov 08, 2019
77.87K
Sale
Scheduled
Nov 06
Form 4
-16.71%
-15.65K
$13.26
-$242.84K
Sep 20, 2019
82.22K
Sale
Scheduled
Sep 18 - Sep 20
Form 4
60.00K
Feb 15, 2019
60.00K
Grant
Feb 13
Form 4
$13.00
$8.81K
Dec 21, 2018
23.97K
Options
Dec 20
Form 4
24.49%
4.00K
$13.26
$53.06K
Nov 15, 2018
23.29K
Purchase
Nov 13
Form 4
-20.63%
-24.00K
$15.01
-$456.29K
Apr 27, 2018
95.29K
Sale
Apr 26 - Apr 27
Form 4
30.00K
Feb 16, 2018
30.00K
Grant
Feb 14
Form 4
-14.08%
-46.30K
$16.13
-$1.12M
Nov 15, 2017
285.50K
Sale
Nov 13 - Nov 15
Form 4
312.50K
May 22, 2017
312.50K
Grant
Feb 10
Form 4
-24.94%
-5.11K
$5.40
-$27.57K
Mar 23, 2017
18.33K
Sale
Mar 21
Form 4
-0.94%
-195.00
$4.52
-$880.50
Feb 01, 2017
21.13K
Sale
Scheduled
Feb 01
Form 4
-0.60%
-125.00
$5.15
-$643.75
Jan 10, 2017
21.33K
Sale
Scheduled
Jan 09
Form 4
100.00K
Dec 23, 2016
100.00K
Grant
Dec 22
Form 4
-0.72%
-150.00
$5.25
-$787.50
Nov 03, 2016
21.20K
Sale
Scheduled
Nov 01
Form 4
-0.60%
-2.50K
$0.45
-$1.12K
Oct 11, 2016
427.03K
Sale
Scheduled
Oct 07
Form 4
-4.60%
-19.81K
$0.78
-$15.55K
Mar 22, 2016
424.53K
Sale
Mar 22
Form 4
136.64%
248.95K
Feb 29, 2016
444.34K
Grant
Feb 25
Form 4
-4.92%
-9.07K
$0.83
-$7.56K
Aug 18, 2015
179.87K
Disposition
Aug 14
Form 4
-4.66%
-9.02K
$4.01
-$36.17K
Mar 20, 2015
188.94K
Disposition
Mar 18
Form 4
88.66%
125.00K
$3.83
$277.68K
Mar 02, 2015
270.46K
Grant
Feb 26
Form 4
-1.20%
-1.68K
$5.67
-$9.51K
Dec 01, 2014
139.23K
Sale
Nov 26
Form 4
-0.73%
-1.03K
$5.03
-$5.19K
Nov 24, 2014
140.91K
Sale
Scheduled
Nov 24
Form 4
-3.03%
-4.39K
$3.89
-$17.08K
Nov 17, 2014
141.94K
Sale
Nov 13
Form 4
-4.35%
-6.58K
$4.61
-$30.32K
Aug 18, 2014
146.33K
Sale
Aug 15
Form 4
-1.73%
-2.67K
$6.32
-$16.87K
Mar 20, 2014
152.91K
Sale
Mar 18
Form 3
Mar 03, 2014
155.58K
Showing 39 results

Monterey Bio Acquisition Corp

Investor
Updated Sep 30, 2021
Form 3
Sep 30, 2021
35.00K
Showing 1 results

PALISADE BIO, INC.

Investor
Updated Feb 13, 2024
Form 4
Feb 13, 2024
29.96K
Options
Feb 09
Form 4
12.70K
Nov 24, 2023
12.70K
Grant
Nov 21
Form 4
17.26K
Jun 13, 2023
17.26K
Grant
Jun 11
Form 4
48.34K
Feb 10, 2022
48.34K
Grant
Nov 18
Form 4
16.40K
Apr 29, 2021
16.40K
Grant
Apr 27
Form 3
Apr 29, 2021
Showing 6 results

Processa Pharmaceuticals, Inc.

Investor
Updated Sep 18, 2025
Form 4/A
615.62%
31.21K
Sep 18, 2025
36.28K
Grant
Sep 03
Form 4
31.21K
Sep 18, 2024
31.21K
Grant
Sep 03
Form 4
703.58%
101.36K
Jul 24, 2023
115.77K
Options
Jun 27
Form 4
17.80K
Jul 21, 2022
17.80K
Grant
Jul 19
Form 3
Jul 21, 2022
Showing 5 results

Peak Bio, Inc.

Investor
Updated May 02, 2023
Form 4
33.34K
May 02, 2023
33.34K
Grant
Apr 28
Form 3
Nov 03, 2022
Showing 2 results